1-4 cm 갑상선 유두상암의 초기 수술로 엽절제술의적용
Thyroid Lobectomy as an Initial Treatment Option on 1-4 cm Papillary Cancer
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Recently, the early diagnosis and treatment of differentiated thyroid cancer has significantly increased theproportion of thyroid lobectomy rather than total thyroidectomy. Thyroid lobectomy is recommended for less than1 cm and total thyroidectomy for more than 4 cm except in unusual cases. There are still controversies in papillarycancer, which size from 1 to 4 cm. There are some reports that the indiscriminate expansion of thyroid lobectomyresults in inferior results on the recurrence rate and survival rate compared to total thyroidectomy. But severalother studies revealed that the recurrence after lobectomy could be diagnosed, it would not increase the rateof locoregional recurrence and mortality. It is necessary to make efforts to completely remove the cancer andlymph node metastasis, even in unilateral multiple papillary cancers, microscopic or gross invasion to the strapmuscles (T3b), even in patients with lateral metastasis, or microscopic central lymph node metastasis. Althoughthe proportion of these patients is nearly half of all 1-4 cm patients with papillary cancer, thyroid lobectomy maybe considered as an alternative treatment to total thyroidectomy for patients with 1-4 cm papillary cancer.
Abstract
Recently, the early diagnosis and treatment of differentiated thyroid cancer has significantly increased theproportion of thyroid lobectomy rather than total thyroidectomy. Thyroid lobectomy is recommended for less than1 cm and total thyroidectomy for more than 4 cm except in unusual cases. There are still controversies in papillarycancer, which size from 1 to 4 cm. There are some reports that the indiscriminate expansion of thyroid lobectomyresults in inferior results on the recurrence rate and survival rate compared to total thyroidectomy. But severalother studies revealed that the recurrence after lobectomy could be diagnosed, it would not increase the rateof locoregional recurrence and mortality. It is necessary to make efforts to completely remove the cancer andlymph node metastasis, even in unilateral multiple papillary cancers, microscopic or gross invasion to the strapmuscles (T3b), even in patients with lateral metastasis, or microscopic central lymph node metastasis. Althoughthe proportion of these patients is nearly half of all 1-4 cm patients with papillary cancer, thyroid lobectomy maybe considered as an alternative treatment to total thyroidectomy for patients with 1-4 cm papillary cancer.
참고문헌 (27)
- American Thyroid Association(ATA)Guidelines Taskforce on Thyroid Nodules, "Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer", Thyroid, 19(11), pp.1167~1214 (2009)
- Haugen BR, "2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer : the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer", Thyroid, 26(1), pp.1~133 (2016)
- Tuttle RM, "Updated American Joint Committee on cancer", tumor-node-metastasis staging system for differentiated and anaplastic thyroid cancer, 2017, pp.27(6), 751~756
- Suman P, "Thyroid lobectomy for T1b-T2 papillary thyroid cancer with high-risk features", J Am Coll Surg, 230(1), pp.136~144 (2020)
- Bilimoria KY, "Impact of surgical treatment on outcomes for papillary thyroid cancer", Adv Surg, 42, pp.1~12 (2008)
- Clark RL Jr, "Total thyroidectomy for cancer of the thyroid : significance of intraglandular dissemination", Ann Surg, 149(6), pp.858~866 (1959)
- Rose RG, "Follow-up study of thyroid cancer treated by unilateral lobectomy", Am J Surg, 106, pp.494~500 (1963)
- Clark OH, "Total thyroidectomy : the treatment of choice for patients with differentiated thyroid cancer", Ann Surg, 196(3), pp.361~370 (1982)
- Bilimoria KY, "Extent of surgery affects survival for papillary thyroid cancer", Ann Surg, 246(3), pp.375~381 (2007)[DOI]
- Barney BM, "Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer", Head Neck, 33(5), pp.645~649 (2011)
- Machens A, "The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma", Cancer, 103(11), pp.2269~2273 (2005)
- Hay ID, "Unilateral total lobectomy : is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma?", Surgery, 124(6), pp.958~964 (1998)[DOI]
- Wanebo H, "Total thyroidectomy does not enhance disease control or survival even in high-risk patients with differentiated thyroid cancer", Ann Surg, 227(6), pp.912~921 (1998)
- Mendelsohn AH, "Surgery for papillary thyroid carcinoma : is lobectomy enough?", Arch Otolaryngol Head Neck Surg, 136(11), pp.1055~1061 (2010)
- Song E, "Lobectomy is feasible for 1-4 cm papillary thyroid carcinomas : a 10-year propensity score matched-pair analysis on recurrence", Thyroid, 29(1), pp.64~70 (2019)
- Kebebew E, "Total thyroidectomy or thyroid lobectomy in patients with low-risk differentiated thyroid cancer : surgical decision analysis of a controversy using a mathematical model", World J Surg, 24(11), pp.1295~1302 (2000)
- Albinsaad LS, "The appropriateness of thyroid lobectomy for preoperatively detected unilateral multifocal papillary carcinoma as initial surgery", Asian J Surg, 44(8), pp.1050~1055 (2021)
- Kim TH, "Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma", Oral Oncol, 71, pp.81~86 (2017)
- Tam S, "Survival in differentiated thyroid cancer:comparing the AJCC cancer staging seventh and eighth editions", Thyroid, 28(10), pp.1301~1310 (2018)
- Park SY, "Prognostic significance of gross extrathyroidal extension invading only strap muscles in differentiated thyroid carcinoma", Br J Surg, 105(9), pp.1155~1162 (2018)
- Nishino M, "Invasion in thyroid cancer : controversies and best practices", Semin Diagn Pathol, 37(5), pp.219~227 (2020)
- Yoon JK, "Strap muscle invasion in differentiated thyroid cancer does not impact disease-specific survival : a population-based study", Sci Rep, 10(1), pp.18248~ (2020)
- Urken ML, "Management of well-differentiated thyroid cancer in 2010 : perspectives of a head and neck surgical oncologist", Endocr Pract, 16(5), pp.903~912 (2010)
- "Thyroid (Version 3.2020)" (2020)[URL]
- Fujiwara T, "Is surgical resection without radioactive iodine treatment a safe alternative treatment for T1-2N1bM0 papillary thyroid carcinoma?", Auris Nasus Larynx, 48(1), pp.148~153 (2021)
- Kluijfhout WP, "Frequency of high-risk characteristics requiring total thyroidectomy for 1-4 cm well-differentiated thyroid cancer", Thyroid, 26(6), pp.820~824 (2016)
- 김완욱, "갑상선유두암의 적절한 수술 범위", International Journal of Thyroidology, 13(2), pp.72~78 (2020), 대한갑상선학회[DOI]